FR3021224A1 - PHYTOMEDICAMENT FOR HIV - Google Patents

PHYTOMEDICAMENT FOR HIV Download PDF

Info

Publication number
FR3021224A1
FR3021224A1 FR1401199A FR1401199A FR3021224A1 FR 3021224 A1 FR3021224 A1 FR 3021224A1 FR 1401199 A FR1401199 A FR 1401199A FR 1401199 A FR1401199 A FR 1401199A FR 3021224 A1 FR3021224 A1 FR 3021224A1
Authority
FR
France
Prior art keywords
plants
roots
pharmaceutical compound
capsules
genus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR1401199A
Other languages
French (fr)
Other versions
FR3021224B1 (en
Inventor
Henri Charles Ainadou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1401199A priority Critical patent/FR3021224B1/en
Publication of FR3021224A1 publication Critical patent/FR3021224A1/en
Application granted granted Critical
Publication of FR3021224B1 publication Critical patent/FR3021224B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Composé pharmaceutique solide ou liquide bien toléré est une association de plantes africaines ayant des actions synergiques pour améliorer la santé des personnes vivants avec le VIH, il s'agit d'une association de cinq plantes que sont : racines d'Imperata cylindrica, racines et feuilles de moringa oleifeira, de racines de paspalum conjugatum, et racines de Fagara xanthoxyloïdes et de racines de cyathea aethiopica. Ce produit est obtenu en séchant dans un premier temps ces différentes racines et graines à l'ombre. Ensuite elles sont broyées, tamisées de façon à obtenir une poudre fine. Les différentes poudres mélangées et réparties dans des gélules vides préalablement bien nettoyées et mises dans de petits flacons de 20, 50 ou 100 gélules. Composé pharmaceutique solide peut être plus concentré, puis complétée par un solvant. Ensuite chaque flacon est placé dans un appareil approprié pendant une semaine environ. On procède au mélange des poudres enrichies obtenues à l'aide d'un mélangeur-malaxeur. Ces gélules peuvent même être mises sous blister. La forme liquide Les différentes poudres sont pesées et prises en quantités appropriées, le mélange est effectué dans un grand récipient, puis il est ajouté un solvant. Le Composé pharmaceutique solide et liquide a une action antivirale, antibactérienne et stimulant du système immunitaire.Well tolerated solid or liquid pharmaceutical compound is a combination of African plants with synergistic actions to improve the health of people living with HIV, it is a combination of five plants that are: Imperata cylindrica roots, roots and leaves of moringa oleifeira, roots of paspalum conjugatum, and xanthoxyloid Fagara roots and roots of cyathea aethiopica. This product is obtained by first drying these different roots and seeds in the shade. Then they are crushed, sieved to obtain a fine powder. The various powders are mixed and distributed in empty capsules that have been thoroughly cleaned and put in small bottles of 20, 50 or 100 capsules. Solid pharmaceutical compound may be more concentrated and then supplemented with a solvent. Then each vial is placed in a suitable device for about a week. The enriched powders obtained are mixed using a mixer-mixer. These capsules can even be blistered. The liquid form The different powders are weighed and taken in appropriate quantities, the mixture is made in a large container, and then a solvent is added. The solid and liquid pharmaceutical compound has an antiviral, antibacterial and immune system stimulating action.

Description

La présente invention concerne un phytomédicament solide ou liquide utile pour la santé des personnes vivantes avec le VIH, agissant comme un antiviral puissant, un stimulant du système immunitaire ainsi qu'un antibactérien contre les maladies opportunistes. Le VIH est une affection virale qui crée un déficit important dans le système immunitaire ouvrant la porte à toutes sortes infections opportunistes. Aujourd'hui les Antirétroviraux constituent un arsenal important dans le dispositif de prise en charge du VIH. A côté de ces médicaments, la phytothérapie occupe une place de choix et permet en Afrique à ceux-là qui n'ont pas accès aux Antirétroviraux de s'en sortir.The present invention relates to a solid or liquid phytomedicine useful for the health of persons living with HIV, acting as a powerful antiviral, an immune system stimulant and an antibacterial against opportunistic diseases. HIV is a viral disease that creates a significant deficit in the immune system that opens the door to all sorts of opportunistic infections. Today antiretrovirals are an important arsenal in the HIV management system. Alongside these drugs, phytotherapy occupies a place of choice and allows those in Africa who do not have access to antiretrovirals to get by.

Les plantes médicinales utilisées pour diminuer les troubles liés à l'immunodéficience acquise sont nombreuses. Les populations qui disposent dans leur patrimoine culturel des plantes médicinales utiles pour le traitement des troubles liés à la déficience immunitaire emploient ces dernières sans aucune rigueur scientifique. Cela ne les protège pas totalement ni contre la maladie ni d'autres problèmes de Santé (atteinte des reins, de la rate, effet toxique) La présente invention permet de remédier à la baisse de l'immunité et de lutter efficacement contre les maladies opportunistes. Le Composé pharmaceutique solide ou liquide, un médicament à base de plantes rigoureusement sélectionnées et testées a un double rôle à savoir, améliorer le système immunitaire et lutter efficacement contre les maladies opportunistes.The medicinal plants used to reduce the disorders related to the acquired immunodeficiency are numerous. People who have medicinal plants in their cultural heritage that are useful for the treatment of disorders linked to immune deficiency use the latter without any scientific rigor. This does not protect them completely or against the disease or other health problems (kidney, spleen, toxic effect) The present invention makes it possible to remedy the decline in immunity and effectively fight against opportunistic diseases . The solid or liquid pharmaceutical compound, a rigorously selected and tested herbal medicine has a dual role namely, to improve the immune system and effectively fight against opportunistic diseases.

Le Composé pharmaceutique solide ou liquide qui vient résoudre ces différents problèmes et complications, se veut bien un médicament efficace dans l'amélioration du système immunitaire mais est également utilisé efficacement à titre curatif lorsque les maladies opportunistes sont installées. Selon un premier aspect de l'invention, il est sous forme de gélule comprenant une association de quatre plantes à savoir : Extraits totaux de plantes de la famille des Graminées, du genre Imperata, plus particulièrement de l'espèce Imperata cylindrica, Extraits totaux de plantes de la famille des graminées d'un genre paspalum, plus particulièrement de l'espèce paspalum conjugatum, Extraits totaux de plantes de la famille moringacées, d'un genre moringa, plus particulièrement de l'espèce moringa oléifeira. Extraits totaux de plantes de la famille des rutacées d'un genre fagara, plus particulièrement de l'espèce fagara Xanthoxyloïdes, Extraits totaux de plantes de la famille des ptéridophytes d'un genre cyathea, plus particulièrement de l'espèce cyathea aethiopica. La Forme Solide Ainsi, sous forme solide, le composé pharmaceutique peut être obtenu en séchant dans un premier temps ces différentes racines et graines à l'ombre. Ensuite elles sont broyées, tamisées de façon à obtenir une poudre fine. Les différentes poudres sont pesées, prises dans des proportions définies, elles sont mélangées et réparties dans des gélules vides préalablement bien conservées et mises dans de petits flacons de 20, 50 ou 100 gélules. Le phytomédicament solide peut selon une autre méthode scientifique avoir un aspect plus concentré : pour ce faire il faut peser chaque poudre à mettre dans un solvant approprié. Ensuite chaque flacon est placé dans un appareil appelé « rotavapor », que l'on laisse tourner pendant une semaine environ. Il sert à l'enrichissement et à la concentration des principes actifs. Ce qui permet de rendre plus performant le produit. On procède au mélange avec un appareil appelé mélangeur-malaxeur pour un mélange plus rigoureux et on répartit les poudres dans les gélules. Ces gélules peuvent être mises sous blister et on peut utiliser à ce niveau des excipients. La forme liquide Selon un autre aspect de l'invention, il est fourni une solution du composé ; les différentes poudres prises en quantités appropriées, le mélange est effectué dans un grand récipient en inox, puis il est ajouté de l'alcool éthylique à 40° ou du Gin Royal à raison de 100g de poudre pour un litre d'alcool. Le mélange est fait à l'aide de spatule ou de louche et est filtré puis réparti dans les flacons. Le Composé pharmaceutique solide et liquide a une action antivirale, antibactérienne et stimulante du système immunitaire. INDICATIONS : Améliore la santé des Personne vivants avec le VIH POSOLOGIE Gélules : 2 gélules matin et soir au milieu des repas Solution : une cuillérée à soupe matin et soir au milieu des repas Précaution d'emploi : Insuffisance rénale PRESENTATION En gélules boite de 50, de 100 et en boite de 20.The solid or liquid pharmaceutical compound that comes to solve these various problems and complications, is an effective drug in the improvement of the immune system but is also used effectively for healing when opportunistic diseases are installed. According to a first aspect of the invention, it is in the form of a capsule comprising an association of four plants, namely: Total extracts of plants of the family Gramineae, of the genus Imperata, more particularly of the species Imperata cylindrica, total extracts of plants of the family of grasses of a genus paspalum, more particularly of the species paspalum conjugatum, total extracts of plants of the moringaceae family, of a moringa genus, more particularly of the species moringa oléifeira. Total extracts of plants of the rutaceae family of a fagara genus, more particularly of the fagara Xanthoxyloïdes species, total extracts of plants of the pteridophyte family of genus cyathea, more particularly of the species cyathea aethiopica. Solid Form Thus, in solid form, the pharmaceutical compound can be obtained by drying these different roots and seeds in the first place in the shade. Then they are crushed, sieved to obtain a fine powder. The different powders are weighed, taken in defined proportions, they are mixed and distributed in empty capsules previously well preserved and put in small bottles of 20, 50 or 100 capsules. The solid phytomedicament can according to another scientific method have a more concentrated appearance: to do this we must weigh each powder to put in a suitable solvent. Then each bottle is placed in a device called "rotavapor", which is allowed to rotate for a week or so. It is used for the enrichment and concentration of active ingredients. This makes the product more efficient. Mixing is carried out with an apparatus called mixer-kneader for a more rigorous mixture and the powders are distributed in the capsules. These capsules may be blistered and excipients may be used at this level. The liquid form According to another aspect of the invention, there is provided a solution of the compound; the various powders taken in appropriate quantities, the mixture is made in a large stainless steel container, then is added 40 ° ethyl alcohol or Royal Gin at a rate of 100g of powder per liter of alcohol. The mixture is made using a spatula or ladle and is filtered and then distributed in the flasks. The solid and liquid pharmaceutical compound has an antiviral, antibacterial and stimulating action of the immune system. INDICATIONS: Improves the health of people living with HIV DOSAGE Capsules: 2 capsules morning and evening in the middle of meals Solution: one tablespoon morning and evening in the middle of meals Precaution for use: Kidney failure PRESENTATION In capsules box of 50, of 100 and in box of 20.

En solution flacon de 1litre et en solution flacon de 250 ml.In 1 liter bottle solution and in 250 ml bottle.

Claims (4)

REVENDICATIONS1-Composé pharmaceutique pour les personnes vivantes avec le VIH comprenant: Extraits totaux de plantes de la famille des Graminées, du genre Imperata, plus particulièrement de l'espèce Imperata cylindrica, Extraits totaux de plantes de la famille des graminées particulièrement de l'espèce paspalum conjugatum, Extraits totaux de plantes de la famille moringacées, particulièrement de l'espèce moringa oléifeira. Extraits totaux de plantes de la famille des particulièrement de l'espèce fagara Xanthoxyloïdes, Extraits totaux de plantes de la famille des ptéridophytes d'un particulièrement de l'espèce cyathea aethiopica ;CLAIMS1-Pharmaceutical compound for persons living with HIV comprising: Total extracts of plants of the family Gramineae, of the genus Imperata, more particularly of the species Imperata cylindrica, total extracts of plants of the family of grasses particularly of the species paspalum conjugatum, Total extracts of plants of the family Moringaceae, particularly of the species moringa oléifeira. Total extracts of plants of the family of the species particularly fagara Xanthoxyloids, total extracts of plants of the family of pteridophytes of a particular species cyathea aethiopica; 2-Composé pharmaceutique selon la revendication 1 caractérisé en ce que sous forme solide, il peut être obtenu en séchant les différentes racines et graines à l'ombre, elles sont ensuite broyées, tamisées, prises dans des proportions définies, elles sont mélangées et réparties dans des gélules et disposées dans des flacons de 20, 50 ou 100 gélules.2-Pharmaceutical compound according to claim 1 characterized in that in solid form, it can be obtained by drying the different roots and seeds in the shade, they are then crushed, sieved, taken in defined proportions, they are mixed and distributed in capsules and placed in bottles of 20, 50 or 100 capsules. 3-Composé pharmaceutique selon les revendications 1 et 2 caractérisé en ce que sous forme plus concentré, les différentes poudres dans un solvant donné, chaque flacon est placé dans un appareil approprié que l'on laisse tourner pendant une semaine environ, pour la concentration des principes actifs. On procède à un mélange plus rigoureux des poudres et à la répartition dans des 20 gélules, qui peuvent même être mises sous blister, des excipients peuvent être utilisés.3-Pharmaceutical compound according to claims 1 and 2 characterized in that in more concentrated form, the various powders in a given solvent, each vial is placed in a suitable apparatus that is allowed to rotate for a week or so, for the concentration of active subtances. More rigorous mixing of the powders and distribution into capsules, which can even be blistered, excipients can be used. 4-Composé pharmaceutique selon les revendications 1 et 2 caractérisé en ce que sous forme liquide, les différentes poudres prises dans des proportions définies, le mélange est effectué avec un solvant dans un récipient. d'un genre paspalum, plus d'un genre moringa, plus rutacées d'un genre fagara, plus genre cyathea, plus4-Pharmaceutical compound according to claims 1 and 2 characterized in that in liquid form, the various powders taken in defined proportions, mixing is carried out with a solvent in a container. of a genus paspalum, more of a genus moringa, more rutaceous of a genus fagara, more genus cyathea, more
FR1401199A 2014-05-26 2014-05-26 PHYTOMEDICAMENT FOR HIV Expired - Fee Related FR3021224B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1401199A FR3021224B1 (en) 2014-05-26 2014-05-26 PHYTOMEDICAMENT FOR HIV

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1401199A FR3021224B1 (en) 2014-05-26 2014-05-26 PHYTOMEDICAMENT FOR HIV

Publications (2)

Publication Number Publication Date
FR3021224A1 true FR3021224A1 (en) 2015-11-27
FR3021224B1 FR3021224B1 (en) 2017-11-17

Family

ID=52423735

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1401199A Expired - Fee Related FR3021224B1 (en) 2014-05-26 2014-05-26 PHYTOMEDICAMENT FOR HIV

Country Status (1)

Country Link
FR (1) FR3021224B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108355081A (en) * 2018-03-27 2018-08-03 江苏娘亲亲母婴健康管理有限公司 A kind of Chinese medicine preparation of immune promotion
FR3080283A1 (en) * 2018-04-19 2019-10-25 Henri Charles Ainadou PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST FIEVRE LASSA
FR3080280A1 (en) * 2018-04-19 2019-10-25 Henri Charles Ainadou PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST EBOLA FEVER
FR3080281A1 (en) * 2018-04-19 2019-10-25 Henri Charles Ainadou PHYTOMEDICAMENT WITH ANTIVIRAL ACTIVITY AGAINST VIRAL HEPATITIS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2855056A1 (en) * 2002-01-18 2004-11-26 Fagla Jerome Medegan Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthyloxyloides and Securidaca longepedonculata and/or Uvaria chamae
FR2859107A1 (en) * 2003-08-26 2005-03-04 Oyoubi Pierre Pyebi USE OF THE EXTRACTS OF A GRAMINEE, A RUTACEE AND A PIERIDOPHYTE IN A PHARMACEUTICAL COMPOSITION WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL ACTIVITY AND ALSO INTENDED TO STIMULATE IMMUNE DEFENSES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2855056A1 (en) * 2002-01-18 2004-11-26 Fagla Jerome Medegan Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthyloxyloides and Securidaca longepedonculata and/or Uvaria chamae
FR2859107A1 (en) * 2003-08-26 2005-03-04 Oyoubi Pierre Pyebi USE OF THE EXTRACTS OF A GRAMINEE, A RUTACEE AND A PIERIDOPHYTE IN A PHARMACEUTICAL COMPOSITION WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL ACTIVITY AND ALSO INTENDED TO STIMULATE IMMUNE DEFENSES

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Moringa Leaves Powder Preparation", INTERNET CITATION, 10 March 2013 (2013-03-10), pages 1 - 5, XP002715420, Retrieved from the Internet <URL:http://miracletrees.org/moringa_leaves_powder.html> [retrieved on 20131024] *
DATABASE CAPLUS, [online] 15 April 2009 (2009-04-15), SHANG ZHENG: "MEDICATED TEA COMPRISING RADIX PUERARIAE, LALANG GRASS RHIZOMA AND RHIZOMA PHRAGMITIS, AND ITS PREPARATION METHOD", XP002670672, retrieved from CAPLUS Database accession no. 2009-460408 2009-460408 *
J. M. CALDERON-MONTANO ET AL: "A Review on the Dietary Flavonoid Kaempferol", MINI-REVIEWS IN MEDICINAL CHEMISTRY, 1 April 2011 (2011-04-01), pages 298 - 344, XP055093966, Retrieved from the Internet <URL:http://www.eurekaselect.com/openurl/content.php?genre=article&issn=13895575&volume=11&issue=4&spage=298> DOI: 10.2174/138955711795305335 *
MONERA TG ET AL: "Moringa oleifera supplementation by patients on antiretroviral therapy", JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, BIOMED CENTRAL LTD, LONDON, UK, vol. 13, no. Suppl 4, 8 November 2010 (2010-11-08), pages P188, XP021084515, ISSN: 1758-2652, DOI: 10.1186/1758-2652-13-S4-P188 *
POPOOLA JACOB O ET AL: "Local knowledge, use pattern and geographical distribution ofMoringa oleiferaLam. (Moringaceae) in Nigeria", JOURNAL OF ETHNOPHARMACOLOGY, vol. 150, no. 2, 2 October 2013 (2013-10-02), pages 682 - 691, XP028765969, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2013.09.043 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108355081A (en) * 2018-03-27 2018-08-03 江苏娘亲亲母婴健康管理有限公司 A kind of Chinese medicine preparation of immune promotion
FR3080283A1 (en) * 2018-04-19 2019-10-25 Henri Charles Ainadou PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST FIEVRE LASSA
FR3080280A1 (en) * 2018-04-19 2019-10-25 Henri Charles Ainadou PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST EBOLA FEVER
FR3080281A1 (en) * 2018-04-19 2019-10-25 Henri Charles Ainadou PHYTOMEDICAMENT WITH ANTIVIRAL ACTIVITY AGAINST VIRAL HEPATITIS

Also Published As

Publication number Publication date
FR3021224B1 (en) 2017-11-17

Similar Documents

Publication Publication Date Title
Okigbo et al. An appraisal of phytomedicine in Africa
George Concerns regarding the safety and toxicity of medicinal plants-An overview
Germano et al. A pilot study on bioactive constituents and analgesic effects of MyrLiq®, a Commiphora myrrha extract with a high furanodiene content
Rahmatullah et al. Medicinal plants used by various tribes of Bangladesh for treatment of malaria
US8535737B2 (en) Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions
Imanirampa et al. Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: an in vitro evaluation
FR3021224A1 (en) PHYTOMEDICAMENT FOR HIV
Ionescu Are herbal products an alternative to antibiotics?
Al Mamun et al. Flavonoids isolated from Tridax procumbens (TPF) inhibit osteoclasts differentiation and bone resorption
Matraszek-Gawron et al. Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L.
Larit et al. Therapeutics to treat psychiatric and neurological disorders: A promising perspective from algerian traditional medicine
Quinto-Ortiz et al. Pharmacological interaction of quercetin derivatives of tilia americana and clinical drugs in experimental fibromyalgia
Lee et al. Dietary supplementation with Ceriporia lacerata improves learning and memory in a scopolamine-induced amnesia mouse model
Denis-Esdras et al. Ethnobotany study of Loranthaceae, hemiparasitic plants used in traditional medicine by population, in the Sud-Comoé region (Côte d’Ivoire)
Natural Standard Natural Standard Herb & Supplement Guide-E-Book: An Evidence-Based Reference
Da Silva et al. Croton grewioides Baill.(Euphorbiaceae) shows antidiarrheal activity in mice
Izah et al. Research needs of medicinal plants used in the management and treatment of some diseases caused by microorganisms
FR3080282A1 (en) PHYTOMEDICAMENT WITH ANTIBACTERIAL ACTIVITY AGAINST GASTRODUODENAL ULCER AND CROHN&#39;S DISEASE
Koffi et al. Evaluation of Picralima nitida acute toxicity in the mouse
Aljeboory et al. Loranthus europaeus is an alternative medicine in treatment of cyst and mouth inflammation resulted from chemotherapy of breast cancer
Meesakul et al. Hawaiian Plants with Beneficial Effects on Sleep, Anxiety, and Mood, etc.
RU2315616C1 (en) Agent for treatment and prophylaxis of cardiovascular diseases
Madhu et al. Anti-diabetic, anti-cancer activity and associated toxicity of Leucas aspera extract in Wistar albino rats
FR3021222A1 (en) PHYTOMEDICAMENT AGAINST MALARIA
Rasoanaivo et al. Using appropriate methodology and technology for research and development of African traditional medicines

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20151127

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20220105